Vesugen

Vesugen is a short tripeptide bioregulator identified in Khavinson’s peptide bioregulation literature and commonly described by the amino-acid sequence Lys–Glu–Asp (KED). It’s used in research to explore vascular/endothelial signaling and vessel-associated gene-expression regulation.

• Research class: Synthetic tripeptide (often listed as KED: Lys–Glu–Asp)

• Primary research purpose: Studying vascular tissue regulation, including endothelial functional signaling and protein-synthesis–associated cellular responses

• Common research endpoints: Endothelial response markers, inflammation/redox signaling panels, vessel tone/structure–associated biomarkers, and transcriptomic/gene-expression changes linked to vascular regulation

• Classification note: Often grouped under “peptide bioregulators/cytomedins” (short organ/tissue-targeted peptides described in this research tradition)

For research use only. Not for therapeutic or diagnostic applications.